Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CME GroupCME -2.23%83 Intrinsic Value: Projected FCF is $177.27 as of Sep. 22, 2026. GuruFocus rates CME with a GF Score™ of 83/100 and a GF Value™ of $273.40 (Fairly Valued). The stock has 3 warning signs investors should review. Among 509 Capital Markets companies, CME Group ranks worse than 67.19% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-09-22), CME Group's Intrinsic Value: Projected FCF is $177.27. The stock price of CME Group is $269.38. Therefore, CME Group's Price-to-Intrinsic-Value-Projected-FCF of today is 1.5.
The historical rank and industry rank for CME Group's Intrinsic Value: Projected FCF or its related term are showing as below:
CME'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.23 Med: 1.57 Max: 1.9
Current: 1.52
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of CME Group was 1.90. The lowest was 1.23. And the median was 1.57.
CME's Price-to-Projected-FCF is ranked worse than 67.19% of 509
companies
in the Capital Markets industry
Industry Median: 1.01
vs CME: 1.52
CME Group (NAS:CME) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
CME Group's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
269.38
/
177.27082237539
=
1.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group Intrinsic Value: Projected FCF Related Terms
CME Group Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for CME Group's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME vs ICE, MCO, SPGI: Intrinsic Value: Projected FCF Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Price-to-Projected-FCF vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where CME Group's Price-to-Projected-FCF falls into.
CME Group Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $177.27 mean?
CME Group (CME) has a Intrinsic Value: Projected FCF of $177.27 as of Sep. 22, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on CME Group and its competitors. According to the industry distribution chart, CME Group ranks #342 out of 509 companies in the Capital Markets industry, placing it in the top 67.2%.
Is CME Group's Intrinsic Value: Projected FCF too high?
CME Group's current Intrinsic Value: Projected FCF is $177.27. The Capital Markets industry median Intrinsic Value: Projected FCF is 1.01. CME Group's value of $177.27 is 17451.5% above this industry median. Based on the distribution chart, CME Group ranks #342 out of 509 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Intrinsic Value: Projected FCF compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #342 out of 509 companies for Intrinsic Value: Projected FCF. This places CME Group in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 1.01. CME Group's value of $177.27 is 17451.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Capital Markets company?
The median Intrinsic Value: Projected FCF among Capital Markets companies is 1.01, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Intrinsic Value: Projected FCF of $177.27 is 17451.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Intrinsic Value: Projected FCF is 1.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Intrinsic Value: Projected FCF is $177.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Fairly Valued. The stock's GF Value™ is $273.40, compared to a current price of $269.38 — trading 1.5% below its estimated fair value. The current Intrinsic Value: Projected FCF is $177.27 and 17451.5% above the Capital Markets industry median of 1.01. CME Group's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For CME Group (CME), the current Intrinsic Value: Projected FCF is $177.27 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $269.38 is trading 1.5% below its estimated GF Value™ of $273.40.
GuruFocus considers CME Group to be Fairly Valued.
Key valuation signals for CME:
Intrinsic Value: Projected FCF: $177.27
GF Value™: $273.40 vs. price of $269.38 (1.5% below fair value)
Industry Position: 17451.5% above the Capital Markets median (#342 of 509)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
83GF Score
Get the complete analysis for CME
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
